Case Study  ·  Opportunity Assessment

Taking blood draws out of the clinic.

A global medical device manufacturer wanted to understand innovation in decentralized clinical trials beyond classic blood workflows. We assessed the market, leading players and self-sampling devices, and tested trends with experts.

The Client

The client is a global medical device manufacturer. It wanted to understand the prospects for at-home collection and patient-centric workflows.

The Challenge

Trials are moving home.
Follow the blood sample.

Prescouter was asked to map current and future trends in decentralized clinical trials and the leading players developing alternative blood workflows, such as devices for sample self-collection, stabilization and processing.

  • Market

    Trial trends

    Current and future DCT trends.

  • Devices

    Self-collection

    Painless at-home blood sampling.

  • Patients

    Patient-centric workflows

    Collection built around the patient.

Our Approach

Three lenses on a shifting market.

Tech landscape
Painlesssampling devices mapped

Map the devices

We profiled current devices offering painless blood collection and the players behind them.

IP research
Comparedkey device developers

Benchmark the science

Patent research revealed similarities and innovations among current technologies.

Expert interviews
Customerpain points captured

Hear the users

Interviews confirmed secondary trends and surfaced challenges from the customer perspective.

The Outcome

A clear view of the DCT opportunity.

Prescouter delivered an overview of the DCT market opportunity and leading contract research organizations, expert views on blood self-sampling, a landscape of device developers and a comparison of their technical advances. It closed with the customer view on device preferences and unmet needs.

  • Market

    Opportunity size

    With leading CROs in the DCT space.

  • Devices

    Developer landscape

    Self-sampling players compared.

  • Customers

    Unmet needs

    Device preferences from the user side.

Decentralized trials change who collects samples and where. Device makers that design for the patient at home will be ready as trials move.

Let’s Talk

Where could decentralized trials take your devices?

Size the market, compare the players and hear what customers need. Wherever you’re starting from, we’ll help you get there.

Or email [email protected]

Book a Session

Want to skip the email back-and-forth?

Pick a time on our calendar right now.

If you’d like to know the outcome of your submission, please leave your email address